Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:clinicalTrials |
Ongoing clinical trials
|
| gptkbp:collaborations |
Collaborations with biotech companies
|
| gptkbp:employees |
Approximately 200
|
| gptkbp:focusArea |
Biopharmaceuticals
|
| gptkbp:founded |
2002
|
| gptkbp:headquarters |
gptkb:New_Jersey
|
| https://www.w3.org/2000/01/rdf-schema#label |
Chugai Pharma USA
|
| gptkbp:market |
gptkb:United_States
|
| gptkbp:mission |
To contribute to the health of patients
|
| gptkbp:parentCompany |
gptkb:Chugai_Pharmaceutical_Co.,_Ltd.
|
| gptkbp:partnerships |
Various research institutions
|
| gptkbp:products |
Oncology drugs
Rheumatoid arthritis treatments |
| gptkbp:regulatoryCompliance |
FDA_approved_products
|
| gptkbp:research_areas |
Immunology
Neuroscience Oncology |
| gptkbp:researchFocus |
Innovative drug development
|
| gptkbp:subsidiary |
gptkb:Roche_Holding_AG
|
| gptkbp:vision |
To be a leading biopharmaceutical company.
|
| gptkbp:website |
www.chugai-pharma.com
|